Namekawa, T.; Ikeda, K.; Horie-Inoue, K.; Inoue, S.
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells. Cells 2019, 8, 74.
https://doi.org/10.3390/cells8010074
AMA Style
Namekawa T, Ikeda K, Horie-Inoue K, Inoue S.
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells. Cells. 2019; 8(1):74.
https://doi.org/10.3390/cells8010074
Chicago/Turabian Style
Namekawa, Takeshi, Kazuhiro Ikeda, Kuniko Horie-Inoue, and Satoshi Inoue.
2019. "Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells" Cells 8, no. 1: 74.
https://doi.org/10.3390/cells8010074
APA Style
Namekawa, T., Ikeda, K., Horie-Inoue, K., & Inoue, S.
(2019). Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells. Cells, 8(1), 74.
https://doi.org/10.3390/cells8010074